Anzeige
Mehr »
Samstag, 14.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
1.038 Leser
Artikel bewerten:
(2)

Kenyan HealthTech Startup Afya Rekod Launching AI Consumer Data Driven Platform in Support of Global Efforts to Curb Corona Pandemic!

The AI and Blockchain powered platform aim to capture real time users'/patients' health data.

Drive connectivity and engagement between patients, doctors and other health care providers.

The company is sprinting to launch 4 months ahead of original launch plans.

NAIROBI, KENYA / ACCESSWIRE / March 25, 2020 / Kenyan health tech startup Afya Rekod is sprinting to launch its AI and Blockchain built consumer driven health data platform amidst the corona virus pandemic in support of global efforts to curb the disease by providing a portal for people across the world to store their health data in real time, with a special focus on Covid 19.

This advanced system is built to help users store their own health data, access health information and connect to health service providers was set to launch end of July 2020.

The Founder and CEO of Afya Rekod John Kamara said "Afya Rekod is a medical data storage platform that allows patients to store their health records, the medication they take as well as keep journals of their statuses and that of their kids and families. The platform is AI driven and uses various AI modules to help detect abnormalities, detect early out breaks and monitor mobility and evolution of diseases via timely data analytics."

"Africa and most of the third world countries have limited doctors and access to health care services. Lack of patient data in real time makes the problem even more damaging to both patients and health service providers across the continent. Over 65% of Africans live in rural communities that are not connected and are off grid in terms of access to health care services. This is the problem we are trying to solve." Explained Kamara.

However, the ongoing Covid 19 pandemic has shown the world once again that centralized health management systems that rely solely on people walking into a health facility are not sufficient. The world also needs decentralized systems that enable people to update their own records, anytime, anywhere, in multi formats.

One of the critical issues affecting the world during emergencies like this includes inefficiency that leads to untimely deaths due to lack of or limited data, scanty access to health care services, unverified information and lack of, and delayed responses among other things.

"We are fast tracking to launch the platform 4 months ahead of its time to enable the world to capture real time data that will hit map areas where the Corona infections are growing and monitor the growth in real time by collecting user generated information from millions of users across multiple geographic locations to allow for sufficient data analysis in support of the global efforts to curb the disease."

"Afya Rekod comes at a crucial time when the world is experiencing one of the biggest pandemics of its generations and we need to monitor the movement and evolution of the virus very closely to determine the changing nature of symptoms among other things," further stated Kamara.

The growing digitization of health care at a time when the world is required to isolate provides an unprecedented opportunity for the world to come together and unite in efforts.

Afya Rekod is currently in discussions with various entities across governments and developing partners to explore how their efforts can be accelerated urgently for Covid 19.

The platform presents a unique ability to address critical emerging health needs as it has a differentiated product that is centered around the most important entity in a health equation, an individual/a patient which presents a rapidly growing opportunity to launch an AI engine that solves and help the world prevent and monitor the spread of global pandemics like Coronavirus Disease (Covid-19).

For more information or partnerships contact: info@afyarekod.com

Download Image - The Founder and CEO of Afya Rekod, John Kamara: https://bit.ly/2QJOTwd

SOURCE: Afya Rekod



View source version on accesswire.com:
https://www.accesswire.com/582507/Kenyan-HealthTech-Startup-Afya-Rekod-Launching-AI-Consumer-Data-Driven-Platform-in-Support-of-Global-Efforts-to-Curb-Corona-Pandemic

© 2020 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.